Recent Peptide Publications

On July the 5th, the peptide and drug-discovery communities lost one of their greatest pioneers. Dr. Richard Houghten was a visionary scientist whose innovations transformed peptide chemistry, combinatorial chemistry, and modern drug discovery. He was not only an extraordinary researcher but also one of the true architects of the technologies that made it possible to synthesize and screen enormous numbers of compounds efficiently.

A detailed page in memory and honor of Dr. Richard Houghten, will be presented here shortly.

The Novo Nordisk Foundation Center for Protein Design has just moved into its new labs and offices at the University of Copenhagen, with an official inauguration still ahead. Led by Professor Dek Woolfson, a Fellow of the Royal Society and longtime American Peptide Symposium speaker, the center brings biologists, chemists, drug designers, and computer scientists together to design proteins nature never evolved. Built on a grant of roughly 109 million US dollars, it is one of the clearest signs yet that protein design has become a global scientific priority.

Radiopharmaceuticals have emerged as a rapidly evolving field at the interface of medicinal chemistry, molecular imaging, and targeted therapy. Progress in radiopharmaceutical development and translational imaging has rapidly expanded the range of diagnostic and therapeutic tools available for cancer, neurological, cardiovascular, and inflammatory diseases.

ACS Medicinal Chemistry Letters invites submissions for a Special Issue dedicated to Radiopharmaceuticals, highlighting advances in design, synthesis, biological evaluation, and clinical translation of radiolabeled agents.